ClinicalTrials.gg
Drug

Oxymetazoline clinical trials

Also written Afrin, AGN-199201 and Upneeq.

studies test it
44
open now
4
in phase 3
7
first study started
2002

How each study uses Oxymetazoline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Oxymetazoline studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 May 1986 · OCUCLEAR · NDA 018471 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Oxymetazoline
10
Oxymetazoline Hydrochloride
6
Oxymetazoline 0.05% nasal solution
2
Oxymetazoline HCL Cream 1.0%
2
Oxymetazoline Nasal Spray
2

Brand

Afrin
8
Upneeq
2
Rhofade
1

Development codes

AGN-199201
3

Studies by the year they started

44 studies that test it; most in 2014 (9)

Studies that test Oxymetazoline, by start year
YearStudies
20021
20051
20074
20082
20111
20122
20133
20149
20151
20173
20186
20191
20211
20221
20231
20243
20252
20262

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
10
Phase 3
7
Phase 4
13
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 20 · Other 24

Allergan (6) · Mayo Clinic (2) · Richard Cartabuke (2) · Egalet Ltd (2) · RDD Pharma Ltd (2) · Washington University School of Medicine (2) · University of South Florida (2) · Bayer (1)

Often tested with

Tested in the same studies.

Mometasone Furoate (3) · Tetracaine (3) · Epinephrine (2) · Pseudoephedrine (2) · Lidocaine (2) · Ketorolac Tromethamine (2) · Ketorolac (2) · Fluticasone (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Oxymetazoline.

Studies

Open first, then newest update. How each study uses Oxymetazoline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 44

See all 44 studies that test Oxymetazoline →

Given beside what is tested · 5 — Oxymetazoline is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Oxymetazoline

Codes

What other systems call Oxymetazoline · ClinicalTrials.gg INT007941

  • MeSH (NLM) D010109OxymetazolineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 8VLN5B44ZYOXYMETAZOLINEConfirmed FDA, NLM, Wikidata
  • RxNorm 7812Confirmed FDA, Wikidata
  • Wikidata Q417813oxymetazolineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61871OxymetazolineOne source FDA
  • DrugBank DB00935One source Wikidata

Also registered as oxymetazoline hydrochloride (UNII K89MJ0S5VY · RxNorm 106101).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.